Schizophrenia Spectrum and Other Psychotic Disorders
Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here
Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.
Catatonia is a psychomotor syndrome with motor and behavioral symptoms, and can occur in both patients with or without psychiatric illness. Discover the latest research on Catatonia here.
Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.
There is ongoing debate regarding the handling of comorbidity in psychiatric disorders, and determining whether the issue lies with the categorizations of diagnostic conventions or if there is an underlying pathology that links multiple diseases. Understanding how to give the proper diagnosis/diagnoses would allow for optimal management of the patient. Find the latest research on comorbidity in psychiatry here.
Psychiatric disorders are known to be multifaceted in their pathophysiology. Because epigenetic changes can be sensitive to the environment, inherited, and reversible, the study of epigenetics in psychiatric disease is a logical way to understand the natural history of the disease as well as to develop therapeutics. Find the latest research on epigenetics and psychiatry here.
Forensic psychiatry includes the relationship between psychiatric abnormalities and legal violations and crimes. Discover the latest research on forensic psychiatry here.
Schizophrenia is a complex mental disease caused by a combination of serial alterations in genetic and environmental factors, including inflammation and immunity. Here is the latest research.
Neuropsychiatry is an emerging field at the intersection of neurology and psychiatry, driven by the unprecedented advances in neuroscience. Here are the latest discoveries in neuropsychiatry.
Paranoid disorders are psychiatric disorders with the suspicion and belief that others are plotting against them, leading to mistrust of others. These symptoms of paranoia can be seen in other psychiatric disorders including dementia and schizophrenia. Here is the latest research on paranoid disorders.
Personality disorders are a class of mental disorders characterized by enduring maladaptive patterns of behavior, cognition, and inner experience, exhibited across many contexts and deviating from those accepted by the individual's culture. Discover the latest research on personality disorders here.
Psychoactive drugs are psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. Here is the latest research on psychoactive drugs and the pathways they modulate.
is the scientific study of the effects drugs have on mood, sensation, thinking, and behavior. It is distinguished from neuropsychopharmacology, which emphasizes the correlation between drug-induced changes in the functioning of cells in the nervous system and changes in consciousness and behavior. Discover the latest research on psychopharmacology here
Psychotherapy is used to change behaviour and treat various psychological diseases. Here is the latest research.
Psychotic affective disorders are a set of psychiatric mood disorders that include depression, bipolar disorder and schizophrenia with psychotic behavior. This is a broad class of psychiatric illnesses and employs a complex individualized treatment plan. Here is the latest research on psychotic affective disorders.
Schizophrenia is a complex disease and emerging studies have identified hundreds of genetic loci harbouring schizophrenia-associated variants. These variants can potentially increase the risk for developing Schizophrenia. Discover the latest research on Risk For Schizophrenia here.
Genome-wide and high-throughput DNA sequencing in Schizophrenia and Bipolar Disorder can be used to identify genes and pathways that contribute to disease risk. Here is the latest research.